Pharmaceuticals

Global Sotrovimab Or Xevudy Market 2026–2030: Forecast Insights for Business Planning

March 6, 2026March 9, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the sotrovimab or xevudy market from 2026–2035 with trusted insights from The Business Research Company

What level of CAGR-driven expansion is anticipated in the Sotrovimab Or Xevudy Market between 2026 and 2030?

The historical growth can be attributed to the emergency approval of COVID-19 monoclonal antibodies, the significant risk of hospitalization during the early stages of the pandemic, the swift rollout of antibody therapies, government acquisition of antiviral treatments, and the expansion of infrastructure for infusion-based treatments.

The growth anticipated for the forecast period can be attributed to the advancement of antibody therapies capable of resisting viral variants, an increasing emphasis on preparing for future pandemics, greater investment in antiviral biologics, the expansion of outpatient infusion services, and the incorporation of monoclonal antibodies into standard medical treatment protocols.

Significant trends during the forecast period include a heightened adoption of monoclonal antibody therapies, an elevated focus on treating viral infections in their early stages, the widening availability of targeted antiviral biologics, a pronounced dedication to safeguarding high-risk patients, and the improved creation of therapeutic agents designed for pandemic response.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20383&type=smp

What Drivers Are Affecting Demand-Supply Dynamics In The Sotrovimab Or Xevudy Market?

The expanding occurrence of COVID-19 infections is anticipated to propel the sotrovimab or xevudy market in the future. COVID-19, an illness resulting from the SARS-CoV-2 virus, transmits via respiratory droplets and can manifest symptoms ranging from mild fever to serious respiratory problems. Its dissemination can be curbed through vaccinations and good hygiene. The surge in COVID-19 cases is attributed to factors like emerging variants, diminishing immunity, relaxed restrictions, seasonal indoor social events, and inconsistent vaccine distribution. Sotrovimab offers treatment to high-risk COVID-19 individuals by neutralizing the virus at an early stage, thereby averting severe repercussions such as hospital admission or fatality. As an illustration, in March 2023, a report from the Office for National Statistics, a UK-based government department for official statistics, indicated that approximately 1.9 million people in the UK (2.9% of the population) had reported COVID. A significant majority (92%) had experienced COVID-19 more than 12 weeks prior, with 69% enduring symptoms for over a year and 41% for over two years. Consequently, the increasing prevalence of COVID cases will stimulate the expansion of the sotrovimab or xevudy market.

How Is The Sotrovimab Or Xevudy Market Organized Into Various Segments?

The sotrovimab or xevudy market covered in this report is segmented –

1) By Indication: COVID-19 Early Treatment, Post-Exposure Prophylaxis

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

3) By End User: Pediatric, Adult, Geriatric

Who Are The Primary Competitors In The Global Sotrovimab Or Xevudy Market?

Major companies operating in the sotrovimab or xevudy market are GSK plc, Vir Biotechnology Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/sotrovimab-or-xevudy-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Sotrovimab Or Xevudy Market?

North America was the largest region in the sotrovimab or xevudy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sotrovimab or xevudy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Sotrovimab Or Xevudy Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20383&type=smp

Browse Through More Reports Similar to the Global Sotrovimab Or Xevudy Market 2026, By The Business Research Company

Hypermarkets Market Report 2026

https://www.thebusinessresearchcompany.com/report/hypermarkets-global-market-report

Data Lake Market Report 2026

https://www.thebusinessresearchcompany.com/report/data-lake-global-market-report

Market Research Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/market-research-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795